IMMUNE THROMBOCYTOPENIA
Clinical trials for IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for low platelet patients: experimental drug shows promise in small trial
Disease control CompletedThis study tested a drug called lusutrombopag in 17 Chinese adults with persistent or chronic immune thrombocytopenia (ITP) who had not responded to standard treatments. The goal was to see if the drug could safely raise their platelet counts to safer levels. Participants took th…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 11:31 UTC
-
New pill shows promise for hard-to-treat blood disorder
Disease control CompletedThis study tested an experimental oral drug called PRN1008 (rilzabrutinib) in 86 adults with immune thrombocytopenia (ITP) whose disease had returned or did not respond to other treatments. The goal was to see if the drug could safely raise platelet counts to reduce bleeding risk…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Principia Biopharma, a Sanofi Company • Aim: Disease control
Last updated May 26, 2026 11:25 UTC
-
New hope for kids with low platelets: drug shows promise in controlling bleeding risk
Disease control CompletedThis study tested a drug called avatrombopag in 75 children aged 1 to 17 with immune thrombocytopenia (ITP) for at least 6 months. The goal was to see if it could safely raise platelet counts to reduce bleeding risk. Children took the drug or a placebo for 12 weeks, and some cont…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for low platelet counts: avatrombopag trial shows promise in chronic ITP
Disease control CompletedThis study tested a drug called avatrombopag in 19 Japanese adults with chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, raising bleeding risk. Participants took the drug for 26 weeks to see if it could safely increase platelet counts…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New registry tracks rare blood disorders in kids to improve care
Knowledge-focused CompletedThis study created a registry for children and young adults with severe immune cytopenias—conditions where the immune system attacks blood cells. Researchers observed 80 participants over up to 4 years, collecting data on symptoms, treatments, and test results. The goal was to im…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated May 26, 2026 11:29 UTC
-
Could cancer trick the body into attacking its own platelets?
Knowledge-focused CompletedThis study looked at 33 adults who had both cancer and immune thrombocytopenia (ITP), a condition where the immune system destroys platelets. Researchers wanted to see if cancer cells and platelets share a protein that confuses the immune system. The main goal was to check if tre…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated May 26, 2026 11:29 UTC